These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9315560)

  • 1. Human platelet Ca2+ mobilization, glycoprotein IIb/IIIa activation, and experimental coronary thrombosis in vivo in dogs are all inhibited by the inotropic agent amrinone.
    Sill JC; Bertha B; Berger I; Uhl C; Nugent M; Folts J
    Circulation; 1997 Sep; 96(5):1647-53. PubMed ID: 9315560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
    Bertha BG; Sill JC; Berger I; Folts JD; Milde JH
    Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically relevant concentrations of dopamine do not amplify agonist-induced human platelet Ca2+ mobilization or GP IIb IIIa activation and do not accelerate acute coronary thrombosis in dogs.
    Sill JC; Bertha B; Berger I; Southorn V; Folts J
    J Cardiovasc Pharmacol; 2009 Mar; 53(3):246-52. PubMed ID: 19247190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotonic and coronary vasodilatatory effects of amrinone in the canine heart-lung preparation with a support dog as compared with those of dobutamine.
    Takeda K; Matsui K; Nakazawa M; Nakahara H; Imai H; Imai S
    Jpn J Pharmacol; 1986 Mar; 40(3):381-8. PubMed ID: 3012165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amrinone (Wincoram)--a new positive inotropic and vasodilator agent].
    Hess W
    Anaesthesist; 1988 Jul; 37(7):400-7. PubMed ID: 3046413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.
    Sauter RJ; Sauter M; Reis ES; Emschermann FN; Nording H; Ebenhöch S; Kraft P; Münzer P; Mauler M; Rheinlaender J; Madlung J; Edlich F; Schäffer TE; Meuth SG; Duerschmied D; Geisler T; Borst O; Gawaz M; Kleinschnitz C; Lambris JD; Langer HF
    Circulation; 2018 Oct; 138(16):1720-1735. PubMed ID: 29802205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amrinone (50 micrograms.kg-1.min-1) does not impair regional myocardial tissue metabolism during the 40%-decrease of left anterior descending coronary flow].
    Tateyama T; Suzuki H; Fukuyama H; Fujiwara R; Abe Y; Okutsu Y
    Masui; 1996 Feb; 45(2):148-52. PubMed ID: 8865700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
    Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
    Circulation; 1997 Sep; 96(5):1445-53. PubMed ID: 9315530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.
    Roux SP; Sakariassen KS; Turitto VT; Baumgartner HR
    Arterioscler Thromb; 1991; 11(5):1182-91. PubMed ID: 1911705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injury.
    Cook JJ; Glass JD; Sitko GR; Holahan MA; Stupienski RF; Wallace AA; Stump GL; Hand EL; Askew BC; Hartman GD; Gould RJ; Lynch JJ
    Circulation; 1997 Aug; 96(3):949-58. PubMed ID: 9264506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amrinone reverses cardiac depression and augments coronary vasodilation with isoflurane in the isolated heart.
    Rooney RT; Stowe DF; Marijic J; Bosnjak ZJ; Kampine JP
    Anesthesiology; 1991 Mar; 74(3):559-67. PubMed ID: 2001035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796.
    Hennan JK; Hong TT; Willens DE; Driscoll EM; Giboulot TA; Lucchesi BR
    Br J Pharmacol; 2002 Jul; 136(6):927-37. PubMed ID: 12110617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor complex prevents platelet aggregation and thrombosis in a canine model of coronary angioplasty.
    Bates ER; McGillem MJ; Mickelson JK; Pitt B; Mancini GB
    Circulation; 1991 Dec; 84(6):2463-9. PubMed ID: 1659954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts.
    Rump AF; Acar D; Klaus W
    Br J Pharmacol; 1994 Jul; 112(3):757-62. PubMed ID: 7921599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
    Kikura M; Kazama T; Ikeda T; Sato S
    Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coronary thrombosis and cell adhesion molecules].
    Ikeda H; Murohara T
    Nihon Rinsho; 1999 Jul; 57(7):1502-7. PubMed ID: 10429448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet activity in vivo by amlodipine alone and combined with aspirin.
    Folts JD
    Int J Cardiol; 1997 Dec; 62 Suppl 2():S111-7. PubMed ID: 9488202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.